BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 4154028)

  • 41. [Prognostic significance of selected side effects occurring in the course of prolonged-action fluphenazine treatment].
    Koślacz A; Popkowska N; Kulesza E; Lysikowska-Prokop L; Marmurowska-Michalowska H; Perzyński J
    Psychiatr Pol; 1977; 11(2):159-64. PubMed ID: 887674
    [No Abstract]   [Full Text] [Related]  

  • 42. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 43. The long-acting phenothiazines.
    Groves JE; Mandel MR
    Arch Gen Psychiatry; 1975 Jul; 32(7):893-900. PubMed ID: 239663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-acting phenothiazines and schizophrenia.
    Morritt C
    Nurs Mirror Midwives J; 1974 Apr; 138(4):57-9. PubMed ID: 4494680
    [No Abstract]   [Full Text] [Related]  

  • 45. Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings].
    Schooler NR; Levine J; Severe JB
    Psychopharmacol Bull; 1979 Apr; 15(2):44-7. PubMed ID: 373006
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluphenazine enantha--a long-acting phenothiazine.
    Med Lett Drugs Ther; 1969 Jan; 11(1):4. PubMed ID: 4911979
    [No Abstract]   [Full Text] [Related]  

  • 47. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

  • 49. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
    Gayral L; Escande M; Fournié H; Perretti A
    Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751
    [No Abstract]   [Full Text] [Related]  

  • 50. [Personal experience with prolonged-action fluphenazine].
    Król K; Krystof J
    Psychiatr Pol; 1974; 8(2):149-55. PubMed ID: 4830322
    [No Abstract]   [Full Text] [Related]  

  • 51. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 52. Fluphenazine: twelve years' experience.
    Ayd FJ
    Dis Nerv Syst; 1968 Nov; 29(11):744-7. PubMed ID: 5752634
    [No Abstract]   [Full Text] [Related]  

  • 53. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 54. Private ambulatory patients treated with fluphenazine enanthate.
    Kline NS; Simpson GM; Swenson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:43-5. PubMed ID: 5476357
    [No Abstract]   [Full Text] [Related]  

  • 55. Therapy with injectable fluphenazines.
    Ayd FJ
    Curr Psychiatr Ther; 1976; 16():177-89. PubMed ID: 991628
    [No Abstract]   [Full Text] [Related]  

  • 56. Our experience with Moditene-Depot in chronic schizophrenia.
    Gamkrelidze ShA; Putkoradze-Gamkrelidze NA
    Act Nerv Super (Praha); 1973 Aug; 15(3):169. PubMed ID: 4769133
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the problem of the therapeutical axis symptom of neuroleptic medicaments].
    Glatzel J
    Psychiatr Neurol Med Psychol (Leipz); 1968 Aug; 20(8):286-95. PubMed ID: 5731884
    [No Abstract]   [Full Text] [Related]  

  • 58. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
    Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].
    Richou H
    Ann Med Psychol (Paris); 1975 Jul; 2(2):399-402. PubMed ID: 9894
    [No Abstract]   [Full Text] [Related]  

  • 60. The long-term use of high doses of fluphenazine enanthate and fluphenazine decanoate.
    Verhaegen JJ
    Compr Psychiatry; 1975; 16(4):357-62. PubMed ID: 1157479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.